Atrial Fibrillation-Bristol-Myers Squibb (AUGUSTUS)
The purpose of this study is to evaluate the capabilities in decreasing blood clots and bleeding events in patients with atrial fibrillation or acute coronary syndrome or in patients who have had previous heart surgery.
Sponsor: Bristol-Myers Squibb
Indicators: Atrial Fibrillation or Acute Coronary Syndrome or Percutaneous Coronary Intervention
Age: 18 years or older
For more information :https://clinicaltrials.gov/ct2/show/NCT02415400
Studies Currently Available At
- Kelowna Cardiology View Location